81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Who owns Vertex Pharmaceuticals?What is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
Institutions own 95.8% of Vertex Pharmaceuticals's shares, through 1,831 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were Capital World Investors (10.3%), BlackRock, Inc. (9.5%), Capital Research Global Investors (7.7%).
- Institutions ownWhat is institutional ownership? Institutional ownership is the share of a company's stock held by funds, banks and other investment managers, as they report it each quarter on Form 13F.
- 95.8%
- Institutional holders
- 1,831
- The 10 largest hold
- 50.5%
- Free floatWhat is free float? Free float is the part of a company's shares that anyone can buy and sell: all its shares minus those held by insiders, founders and owners of over 5%.
- 99.8%
- Holdings as of
- 30 Jun 2026
Who owns the shares
10 largest holders 50.5% Other institutions 45.3% Individuals and others 4.2%
Shares free to trade
Free float 252.88M shares ·99.8% Closely held 579.41K shares ·0.2%
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
The largest shareholders
| # | Holder | Shares | Of the company | Value | Change last quarter (shares) |
|---|---|---|---|---|---|
| 1 | Capital World Investors | 26,115,014 | 10.29% | 12.97B USD | +746,890 |
| 2 | BlackRock, Inc. | 24,109,373 | 9.50% | 11.98B USD | +139,856 |
| 3 | Capital Research Global Investors | 19,490,637 | 7.68% | 9.68B USD | -1,635,327 |
| 4 | Vanguard Capital Management LLC | 16,580,713 | 6.53% | 8.24B USD | +67,903 |
| 5 | State Street Corp | 11,871,459 | 4.67% | 5.90B USD | +141,320 |
| 6 | Invesco Ltd. | 8,043,052 | 3.17% | 4.00B USD | +2,711,498 |
| 7 | JPMorgan Chase & Co | 6,517,600 | 2.57% | 3.26B USD | -515,556 |
| 8 | Geode Capital Management, LLC | 6,017,848 | 2.37% | 2.98B USD | -121,773 |
| 9 | Vanguard Portfolio Management LLC | 4,878,987 | 1.92% | 2.42B USD | -266,622 |
| 10 | Capital International Investors | 4,695,144 | 1.85% | 2.33B USD | -430,933 |
| 11 | Loomis Sayles & Co L P | 3,920,953 | 1.54% | 1.95B USD | -82,868 |
| 12 | Franklin Templeton Inc | 3,347,253 | 1.32% | 1.66B USD | +2,796,121 |
| 13 | Wellington Management Group LLP | 3,247,658 | 1.28% | 1.61B USD | +35,069 |
| 14 | Morgan Stanley | 3,242,139 | 1.28% | 1.61B USD | +53,258 |
| 15 | UBS AM | 3,086,683 | 1.22% | 1.53B USD | +29,287 |
| 16 | Bank Of America Corp | 3,039,178 | 1.20% | 1.51B USD | +160,995 |
| 17 | Alliancebernstein L.P. | 3,019,315 | 1.19% | 1.35B USD | -891,471 |
| 18 | Jennison Associates LLC | 2,998,530 | 1.18% | 1.49B USD | +258,471 |
| 19 | Norges Bank | 2,971,681 | 1.17% | 1.48B USD | New position |
| 20 | Ameriprise Financial Inc | 2,604,822 | 1.03% | 1.29B USD | -28,659 |
| 21 | Northern Trust Corp | 2,486,478 | 0.98% | 1.24B USD | -77,786 |
| 22 | Goldman Sachs Group Inc | 2,481,761 | 0.98% | 1.23B USD | +63,886 |
| 23 | Clearbridge Investments, LLC | 2,342,915 | 0.92% | 1.16B USD | -358,060 |
| 24 | Victory Capital Management Inc | 2,173,152 | 0.86% | 1.08B USD | +284,631 |
| 25 | Sixth Street Partners Management Company, L.P. | 2,041,282 | 0.80% | 1.01B USD | New position |
All institutions last quarter
- Bought or added
- 1,099 · 196 new
- Sold or cut
- 764 · 131 sold out
- Net shares bought
- +8.31M · 4.13B USD
- Institutional ownership
- 92.6% → 95.8%
Biggest buyers last quarter
- Norges BankNew position
- Franklin Templeton Inc+2,796,121
- Invesco Ltd.+2,711,498
- Sixth Street Partners Management Company, L.P.New position
- Jupiter Topco LLCNew position
Biggest sellers last quarter
- Capital Research Global Investors-1,635,327
- Alliancebernstein L.P.-891,471
- FMR LLC-563,107
- JPMorgan Chase & Co-515,556
- Capital International Investors-430,933
From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.
Common questions about Vertex Pharmaceuticals's shareholders
Source: Financial Modeling Prep